Clinical trial
Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients…
NCT00070148 · Wake Forest University Health Sciences, Other · Completed
Key facts
| NCT number | NCT00070148 |
|---|---|
| Title | Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for Cancer |
| Official title | A Phase III Randomized Study Comparing The Effects Of Oxandrolone (Oxandrin) And Megestrol Acetate (Megace) On Lean Body Mass, Weight, Body Fat, And Quality Of Life In Patients With Solid Tumors And Weight Loss Receiving Chemotherapy |
| Lead sponsor | Wake Forest University Health Sciences, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific, Weight Changes |
| Intervention type | Drug |
| Interventions | Megestrol Acetate, Oxandrolone 20 mg |
| Enrollment | 155 |
| Start date | Mar 1, 2004 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Oct 7, 2003 |
| Last update posted | Sep 9, 2021 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: